Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit

被引:14
作者
Chazenbalk, GD
Latrofa, F
McLachlan, SM
Rapoport, B
机构
[1] Univ Calif Los Angeles, Cedars Sinai Res Inst, Autoimmune Dis Unit, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90048 USA
关键词
D O I
10.1210/jc.2003-031554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Whether monoclonal antibodies with thyroid-stimulating activity [thyroid-stimulating antibody/antibodies (TSAb)] from immunized animals are identical to human autoantibodies in Graves' disease is unknown. Here, we compared properties of a monoclonal hamster TSAb (MS-1) with human autoantibodies. The epitopes of neither MS-1 nor human autoantibodies can be determined by peptide scanning, indicating their conformational nature. A property of human TSAb is that their epitope is partially obscured on the TSH holoreceptor on the cell surface relative to the TSH receptor (TSHR) ectodomain tethered to the membrane by a glycosylphosphatidyl inositol anchor. On flow cytometry, as for human autoantibodies, MS-1 preferentially recognized the glycosylphosphatidyl inositol-anchored ectodomain vs. the TSH holoreceptor on Chinese hamster ovary cells. Also, as with human autoantibodies, only A-subunits with the active (but not the inactive) conformation adsorbed MS-1 binding activity. This difference localizes antibody binding to a cysteine-rich region at the TSHR N terminus. Remarkably, active TSHR A-subunit more effectively (similar to40-fold) neutralized human autoantibodies than it did MS-1. Therefore, MS-1 interacts less well than autoantibodies with the free A-subunit. In summary, we provide evidence that TSAb need not have identical epitopes. However, the TSAb epitope does appear to require involvement of the highly conformational N terminus of the A-subunit.
引用
收藏
页码:1788 / 1793
页数:6
相关论文
共 32 条
[1]   A monoclonal thyroid-stimulating antibody [J].
Ando, T ;
Latif, R ;
Pritsker, A ;
Moran, T ;
Nagayama, Y ;
Davies, TF .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (11) :1667-1674
[2]  
[Anonymous], 1956, Proceedings of the University of Otago Medical School
[3]   PHOTO-AFFINITY LABELING OF THE THYROTROPIN RECEPTOR [J].
BUCKLAND, PR ;
RICKARDS, CR ;
HOWELLS, RD ;
JONES, ED ;
SMITH, BR .
FEBS LETTERS, 1982, 145 (02) :245-249
[4]   Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells [J].
Chazenbalk, GD ;
Kakinuma, A ;
Jaume, JC ;
McLachlan, SM ;
Rapoport, B .
ENDOCRINOLOGY, 1996, 137 (11) :4586-4591
[5]   A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies [J].
Chazenbalk, GD ;
Wang, Y ;
Guo, J ;
Hutchison, JS ;
Segal, D ;
Jaume, JC ;
McLachlan, SM ;
Rapoport, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :702-710
[6]   Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor [J].
Chazenbalk, GD ;
Pichurin, P ;
Chen, CR ;
Latrofa, F ;
Johnstone, AP ;
McLachlan, SM ;
Rapoport, B .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (02) :209-217
[7]   A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: Purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies [J].
Chazenbalk, GD ;
McLachlan, SM ;
Pichurin, P ;
Yan, XM ;
Rapoport, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1287-1293
[8]   The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim [J].
Chen, CR ;
Pichurin, P ;
Nagayama, Y ;
Latrofa, F ;
Rapoport, B ;
McLachlan, SM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1897-1904
[9]   A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain [J].
Chen, CR ;
Tanaka, K ;
Chazenbalk, GD ;
McLachlan, SM ;
Rapoport, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14767-14772
[10]   Generation of a mouse monoclonal TSH receptor antibody with stimulating activity [J].
Costagliola, S ;
Franssen, JDF ;
Bonomi, M ;
Urizar, E ;
Willnich, M ;
Bergmann, A ;
Vassart, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (05) :891-896